Literature DB >> 31778237

Success of endodontic management of compromised first permanent molars in children: A systematic review.

Greig D Taylor1, Christopher R Vernazza1, Bana Abdulmohsen1.   

Abstract

BACKGROUND: Endodontic therapies may be required in the management of compromised first permanent molar teeth; their success in children, however, is unknown. AIM: To determine the success of endodontic therapies used on first permanent molar teeth in children aged sixteen and under.
DESIGN: MEDLINE, Embase, Cochrane library, CENTRAL, Clinicaltrials.gov, and the ISRCTN registry as well as relevant paediatric, endodontic, and traumatology journal were searched using a detailed search strategy. References of included studies were hand-searched. A PICOS question was formulated: (P): children aged sixteen and under; (I): endodontic therapies (not pulp capping) on a first permanent molar tooth; (C): no treatment; (O): clinical success of endodontic therapy; and (S): all study types included. Bias was assessed using the Cochrane and Robins-I risk tools. Quality of evidence was assessed using the GRADE approach. Significant heterogeneity precluded meta-analysis.
RESULTS: 4172 studies were retrieved and eleven were included in the narrative review. Partial and coronal pulpotomies have high success rates in the short term and long term. Limited evidence is available for conventional pulpectomy or regenerative techniques.
CONCLUSIONS: Partial and coronal pulpotomies are successful endodontic therapies for use in a compromised child's first permanent molar.
© 2019 BSPD, IAPD and John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  endodontics; pulp biology; restorative dentistry/dental materials

Mesh:

Year:  2019        PMID: 31778237     DOI: 10.1111/ipd.12599

Source DB:  PubMed          Journal:  Int J Paediatr Dent        ISSN: 0960-7439            Impact factor:   3.455


  7 in total

Review 1.  Is pulpotomy a promising modality in treating permanent teeth? An umbrella review.

Authors:  Galvin Sim Siang Lin; Yun Qing Yew; Hern Yue Lee; Ting Low; Manushantini Pillai Muralitharan Pillai; Thittikkon Suvanpratum Laer; Sharifah Wade'ah Wafa Syed Saadun Tarek Wafa
Journal:  Odontology       Date:  2021-10-11       Impact factor: 2.634

2.  Outcome of vital pulp therapy in deeply carious molars affected with molar incisor hypomineralisation (MIH) defects: a randomized clinical trial.

Authors:  Ola B Al-Batayneh; Ibrahim M Abdelghani
Journal:  Eur Arch Paediatr Dent       Date:  2022-06-25

3.  Molar-incisor hypomineralisation combat: exploratory qualitative interviews with general dental practitioners in England regarding the management of children with molar-incisor hypomineralisation.

Authors:  Judith Humphreys; Emma Morgan; Stephen Clayton; Fadi Jarad; Rebecca Harris; Sondos Albadri
Journal:  Br Dent J       Date:  2022-05-26       Impact factor: 2.727

4.  An Evaluation on Deep Caries Removal Method and Management Performed by Undergraduate Dental Students: A Malaysia Experience.

Authors:  Nurin Izyani Othman; Hanan Umaira Ismail; Norazlina Mohammad; Norzalina Ghazali; Muhammad Syafiq Alauddin
Journal:  Eur J Dent       Date:  2020-12-26

Review 5.  Best clinical practice guidance for clinicians dealing with children presenting with molar-incisor-hypomineralisation (MIH): an updated European Academy of Paediatric Dentistry policy document.

Authors:  N A Lygidakis; E Garot; C Somani; G D Taylor; P Rouas; F S L Wong
Journal:  Eur Arch Paediatr Dent       Date:  2021-10-20

Review 6.  Outcomes reporting in systematic reviews on vital pulp treatment: A scoping review for the development of a core outcome set.

Authors:  Siobhan Cushley; Henry F Duncan; Fionnuala T Lundy; Venkateshbabu Nagendrababu; Mike Clarke; Ikhlas El Karim
Journal:  Int Endod J       Date:  2022-06-30       Impact factor: 5.165

7.  Children's dental treatment requirements of first permanent molars with poor prognosis.

Authors:  Aliye Tuğçe Gürcan; Merve Bayram
Journal:  Clin Oral Investig       Date:  2021-07-09       Impact factor: 3.573

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.